Research output per year
Research output per year
Personal profile
About
Dr. Christina Kovacs became the program director at HCA Florida Brandon Hospital in May 2020. She is board certified in anatomic and clinical pathology with additional fellowship training in both cytopathology and head and neck pathology. She completed her residency training and fellowships at Jackson Memorial Hospital/UM. She has published in pathology journals and authored book chapters and has also presented at regional and national meetings on head and neck pathology.
Education/Academic qualification
Fellowship, Selective Pathology, University of Miami
2014 → 2015
Fellowship, Cytopathology, University of Miami
2013 → 2014
Residency, Pathology-Anatomic and Clinical, University of Miami
2009 → 2013
MD, Leonard M. Miller School of Medicine, University of Miami
… → 2009
Research Interests
- Cytopathology
- Head & Neck Pathology
Disciplines
- Medicine and Health Sciences
- Pathology
Research output
- 7 Article
-
Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia: HESTER Phase II Study
Boyer, M. W., Chaudhury, S., Davis, K. L., Driscoll, T. A., Grupp, S., Hermiston, M., John, S., Keating, A. K., Kovacs, C., Magley, A., Myers, G. D., Phillips, C. L., Pulsipher, M. A., Purkayastha, D., Talano, J.-A., Adisa, O. A. & Willert, J., Mar 1 2021, In: Transplantation and Cellular Therapy. 27, 3Research output: Contribution to journal › Article › peer-review
-
HESTER: A Phase II Study Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia Experiencing Loss of B-Cell Aplasia
Boyer, M. W., Chaudhury, S., Davis, K. L., Driscoll, T. A., Grupp, S. A., Hermiston, M., John, S., Keating, A. K., Kovacs, C., Magley, A., Myers, G. D., Phillips, C. L., Pulsipher, M. A., Purkayastha, D., Talano, J.-A. & Willert, J., Nov 5 2020, In: Blood. 136Research output: Contribution to journal › Article › peer-review
-
Phase II study of spartalizumab (PDR001) and LAG525 in advanced solid tumors and hematologic malignancies.
Uboha, N. V., Milhem, M. M., Kovacs, C., Amin, A., Magley, A., Purkayastha, D. D. & Piha-Paul, S. A., May 26 2019, In: Journal of Clinical Oncology. 37Research output: Contribution to journal › Article › peer-review
-
A phase 2, open-label study of the combination of spartalizumab (PDR001) and LAG525 for patients with advanced solid tumors and hematologic malignancies.
Piha-Paul, S. A., Amin, A., Kovacs, C., Magley, A., Purkayastha, D. D. & Zhuo, Y., May 20 2018, In: Journal of Clinical Oncology. 36Research output: Contribution to journal › Article › peer-review
-
A Limited Immunohistochemical Panel to Distinguish Basal Cell Carcinoma of Cutaneous Origin From Basaloid Squamous Cell Carcinoma of the Head and Neck.
Villada, G., Kryvenko, O. N., Campuzano-zuluaga, G., Kovacs, C., Chapman, J. & Gomez-fernandez, C., Jul 19 2016, In: Applied Immunohistochemistry & Molecular Morphology. 26, 2Research output: Contribution to journal › Article › peer-review